关于高级三阴性乳腺癌治疗现状和建议的叙述性综述
1Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
概括
免疫疗法和向疗法的进步改变了三阴性乳腺癌 (TNBC) 治疗. 生物标志物驱动的精准医学是优化高级TNBC患者治疗方案的关键.
科学领域:
- 在瘤学瘤学.
- 医疗治疗 医疗治疗
- 临床研究 临床研究
背景情况:
- 最近的临床试验显示,三阴性乳腺癌 (TNBC) 治疗方案取得了进展.
- 免疫疗法和基于生物标志物的精密疗法正在彻底改变TNBC护理.
- 对临床医生来说,更新高级TNBC的治疗指南至关重要.
研究的目的:
- 审查目前高级TNBC的治疗策略.
- 将国际指导方针和会议建议与CSCO指导方针进行综合.
- 为高级TNBC提供最新的治疗原则.
主要方法:
- 通过PubMed搜索有关先进TNBC治疗 (2014-2022) 的文献.
- 下载并总结了2021-2022年高级TNBC的治疗指南.
- 关于免疫治疗,向治疗,ADC和化疗的综合信息.
主要成果:
- 总结了当前在免疫疗法,向疗法,ADC和化疗中先进的TNBC治疗方法.
- 将国际指导方针和会议建议整合到2022年CSCO指导方针中.
- 强调生物标志物检测对于治疗选择的重要性.
结论:
- 生物标志物检测和评估对于选择TNBC治疗方案至关重要.
- 精确的患者查对于改善晚期TNBC治疗结果和预后至关重要.
- 基于分子分析的个性化治疗方法对于TNBC管理至关重要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


